Our work in ‘Engineering drug design’ involves the development of new drug candidates using innovative approaches and cutting-edge technologies. This includes using computational methods to design molecules that are more likely to be effective in targeting specific disease pathways, and using advanced screening technologies to identify new drug targets or molecules.
Precision medicine, on the other hand, is our approach to healthcare that seeks to tailor treatments to the individual characteristics of each patient. This involves using genomic or other molecular data to identify patients who are most likely to benefit from a particular treatment, or using other methods to personalize treatment based on individual factors such as age, gender, or lifestyle.
Overall, the combination of pioneering drug design and precision medicine represents a major shift in the way we think about drug discovery and development, and has the potential to revolutionize the way we approach healthcare in the future.
Innovation in Biology, Medicines & Clinical Development